Lycopus
FDA Label NDC 60986-1026

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Marco Pharma International Llc. for the product Lycopus (NDC 60986-1026). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, otc - keep out of reach of children, suggested use, warnings, dosage & administration, inactive ingredients, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

LYCOPUS VIRGINICUS 1XHPUS

SPONGIA TOSTA 1XHPUS

LOPHOPHYTUM LEANDRII 6XHPUS

CHININUM ARSENICOSUM 6XHPUS

CALCAREA PHOSPHORICA 8XHPUS

MAGNESIA PHOSPHORICA 8XHPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

FOR THYROID CONDITIONS; HYPERTHYROID WITH PALPITATION.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Suggested Use

ADULTS TAKE 5 DROPS IN 1 TABLESPOON TEPID WATER THREE TIME DAILY, INCREASING BY 1 DROP DAILY UNTIL REACTION LEVEL IS REACHED. MAXIMUM AMOUNT: 20 DROPS THREE TIMES DAILY. CHILDREN RECEIVE 1/2 OR LESS OF THE ADULT AMOUNT.

Warnings

If pregnant or breast-feeding, consult a health professional before use.

Dosage & Administration

(Read Suggested Use Section)

Inactive Ingredients

CONTAINS ETHYL ALCOHOL (53% BY VOL.) AND WATER

Package Label.Principal Display Panel

Label (Lycopus)

Label (Lycopus)

* Please review the disclaimer below.